Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Robust scientific evidence related to two rotavirus (RV) vaccines available worldwide demonstrates their significant impact on RV disease burden. Improving RV vaccination coverage may result in better RV disease control. To make RV vaccination accessible to all eligible children worldwide and improve vaccine effectiveness in high-mortality settings, research into new RV vaccines continues. Although current and in-development RV vaccines differ in vaccine design, their common goal is the reduction of RV disease risk in children <5 years old for whom disease burden is the most significant. Given the range of RV vaccines available, informed decision-making is essential regarding the choice of vaccine for immunization. This review aims to describe the landscape of current and new RV vaccines, providing context for the assessment of their similarities and differences. As data for new vaccines are limited, future investigations will be required to evaluate their performance/added value in a real-world setting.


Volker Vetter, Robert C Gardner, Serge Debrus, Bernd Benninghoff, Priya Pereira. Established and new rotavirus vaccines: a comprehensive review for healthcare professionals. Human vaccines & immunotherapeutics. 2022 Dec 31;18(1):1870395

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 33605839

View Full Text